Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes
复制标题
DOI：
10.1200/jco.2016.66.9705
复制
发表时间：
2016-09-20
影响因子：
45.3
通讯作者：
Florensa, Lourdes
中科院分区：
文献类型：
--
作者：
Arenillas, Leonor;Calvo, Xavier;Florensa, Lourdes
骨髓恶性肿瘤的WHO分类主要依据骨髓原始细胞的百分比。这是从总有核细胞（TNC）中考虑的，除非有红系细胞增生（成红细胞>= 50%），从非红系细胞（NEC）中计算。在这些情况下，当BM母细胞> 20%时，该病症被分类为红白血病，而当BM母细胞> 20%时，
PurposeWHO classification of myeloid malignancies is based mainly on the percentage of bone marrow (BM) blasts. This is considered from total nucleated cells (TNCs), unless there is erythroid-hyperplasia (erythroblasts >= 50%), calculated from nonerythroid cells (NECs). In these instances, when BM blasts are >20%, the disorder is classified as erythroleukemia, and when BM blasts are,